Immune Modulation of HIV Replication: Relevance to HIV Immuno- and Neuro-Pathogenesis
Journal:
Current HIV Research
Volume:
2
Page:
395-401
Author(s):
Elizabeth Z. Managlia, Deborah Carroll, Andrew Zloza and Lena Al-Harthi
Preparation of 2-(4-{[4-(Quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl) Propionic Acid (VUFB 20615) and 2-Methyl-2-(4-{[4-(quinolin-2- ylmethoxy)Phenyl]sulfanyl}phenyl)Propionic Acid (VUFB 20623) as Potential Antileukotrienic Agents
Journal:
Current Organic Chemistry
Volume:
8
Page:
1235-1243
Author(s):
Josef Jampilek, Martin Dolezal, Jiri Kunes, Petra Víchova, Ivan Raich, Daniel Jun, Robert O'Connor and Martin Clynes
Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2935-2950
Author(s):
C. P. Bleeker-Rovers, O. C. Boerman, H. J.J. M. Rennen, F. H. M. Corstens and W. J.G. Oyen
Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2951-2963
Author(s):
M. Gotthardt, O. C. Boermann, T. M. Behr, M. P. Behe and W. J.G. Oyen
Targeted Liposomal Drug Delivery in Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2981-2989
Author(s):
Oula Penate Medina, Ying Zhu and Kalevi Kairemo
Nerve Growth Factor Receptors and Signaling in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
463-470
Author(s):
Laurent Dolle, Eric Adriaenssens, Ikram El Yazidi-Belkoura, Xuefen Le Bourhis, Victor Nurcombe and Hubert Hondermarck
Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
483-499
Author(s):
Thresia Thomas, Michael A. Gallo and T. J. Thomas
Two-Domain Vascular Disruptive Agents in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
501-509
Author(s):
Stanislaw Szala
Mammaglobin-Based Strategies for Treatment of Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
531-542
Author(s):
Peter S. Goedegebuure, Mark A. Watson, Carsten T. Viehl and Timothy P. Fleming
Preface [Hot Topic: Transcription Factors as Targets of Novel Therapeutic Approaches of Autoimmune Diseases (Executive Editor: Gunther Ne)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
ii-ii
Author(s):
Gunther Neeck